Renaud Ronald C JR has filed 4 insider transactions across 2 companies since October 2024.
Most recent transaction: a grant/award of 300000 shares of Kailera Therapeutics, Inc. ($KLRA) on April 16, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 16, 2026 | Kailera Therapeutics, Inc. | $KLRA | Renaud Ronald C JR | CEO & President | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| April 16, 2026 | Kailera Therapeutics, Inc. | $KLRA | Renaud Ronald C JR | CEO & President | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| June 10, 2025 | Upstream Bio, Inc. | $UPB | Renaud Ronald C JR | Not found | A | Stock Option (Right to Buy) | 17096 | $0.00 | 17,096.0000 | 53,640,895 | 9999.99% | 0.03% |
| Oct. 10, 2024 | Upstream Bio, Inc. | $UPB | Renaud Ronald C JR | Not found | A | Stock Option (Right to Buy) | 17096 | $0.00 | 17,096.0000 | 0 | 9999.99% | 0.00% |